LAS VEGAS (AP) — Nvidia CEO Jensen Huang unveiled a suite of new products, services and partnerships at CES 2025. In a packed ...

Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and stands as the second leading cause of cancer-related mortality. Despite ...

This manuscript offers valuable insights by identifying two distinct liver cancer subtypes through multi-omics integration and developing a robust prognostic model, validated across various datasets, ...

When Salmonella enters a body, in some cases it can infect cells in the intestines. Sometimes these bacteria cause serious ...

Discover a groundbreaking cancer treatment from KAIST that transforms colon cancer cells back to healthy ones offering hope for safer side-effect-free therapies ...

Despite advancements in cancer treatment technologies, most therapies share a common goal: eliminating cancer cells. However, ...

Stenoparib is under clinical development by Allarity Therapeutics and currently in Phase I for Colon Cancer. According to GlobalData, Phase I drugs for Colon Cancer have a 56% phase transition success ...

Using a computational “digital twin” model, researchers mapped the gene networks controlling cell differentiation. They ...

Scientists at KAIST have developed a groundbreaking method to convert colon cancer cells into healthy ones using a ...

KAIST researchers have developed new technology that can transform colon cancer cells into normal-like cells. Led by ...

This is a significant departure from traditional cancer treatments that rely on killing cancer cells, often leading to severe ...